"Phenotypic Reprogramming Overcomes Therapeutic Resistance in Advanced Prostate Cancer"

Natasha Kyprianou, MBBS, PhD

Professor of Urology, Oncological Sciences and Pathology & Molecular Medicine

Vice Chair of Research, Department of Urology

NCI-Designated Tisch Cancer Institute

Icahn School of Medicine at Mount Sinai